Transcoronary stem cell delivery using physiological endothelium-targeting perfusion technique: The rationale and a pilot study involving a comparison with conventional over-the-wire balloon coronary occlusions in patients after recent myocardial infarction

Kardiologia Polska

Volumn 64, Issue 5, 2006, Pages 489-498

  Musiałek, Piotr ^a,c   Tracz, Wiesława ^a   Skotnicki, Aleksander B ^a,b   Zmudka, Krzysztof ^a   Pienia̧zek, Piotr ^a   Walter, Zbigniew ^a,b   Szostek, Marta ^a,b   Majka, Marcin ^a,b   Wȩglarska, Dorota ^a,b   Zalewski, Jarosław ^a   Olszowska, Maria ^a   Kostkiewicz, Magdalena ^a   Pasowicz, Mieczysław ^a   Klimeczek, Piotr ^a   Przewłocki, Tadeusz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c Klinika Chirurgii Serca Naczyn i Transplantologii w Szpitalu im Jana Pawła ii w Krakowie   (Poland)

Author keywords

Endothelium targeted stem cell delivery; Myocardial infarction border zone regeneration; Physiological stem cell delivery; Stem cell therapy; Transcoronary bone marrow stem cell transplantation

Indexed keywords

ADULT; AGED; ARTICLE; CATHETERIZATION; CELL VIABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CLONOGENESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEMATOPOIETIC STEM CELL; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION;

EID: 33747299929     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Imhof BA, Aurrand-Lions M. Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol 2004; 4: 432-44.
2. Majka M, Kucia M, Ratajczak MZ. Stem cell biology - a never ending quest for understanding. Acta Biochim Pol 2005; 52: 353-8.
3. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005; 115: 572-83.
4. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430-6.
5. Wang JS, Shum-Tim D, Chedrawy E, et al. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg 2001; 122: 699-705.
6. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-8.
7. Assmus B, Schachinger V, Teupe C, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-17.
8. Siminiak T, Gryglewska B, Jedrzykowska O, et al. Autologous bone marrow stem cell transplantation in acute myocardial infarction: report of two cases. Kardiol Pol 2003; 59: 502-10.
9. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-8.
10. Fernandez-Aviles F, San Roman JA, Garcia-Frade J, et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004; 95: 742-8.
11. Kuethe F, Richartz BM, Sayer HG, et al. Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int J Cardiol 2004; 97: 123-7.
12. Katritsis DG, Sotiropoulou PA, Karvouni E, et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv 2005; 65: 321-9.
13. Bartunek J, Vanderheyden M, Vandekerckhove B, et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 2005; 112 (9 Suppl.): I178-83.
14. Remah HA, Asanoi H, Joho S, et al. Modulation of left ventricular diastolic distensibility by collateral flow recruitment during balloon coronary occlusion. J Am Coll Cardiol 1999; 34: 500-6.
15. Kelley KO, Gould KL. Coronary reactive hyperaemia after brief occlusion and after deoxygenated perfusion. Cardiovasc Res 1981; 15: 615-22.
16. Kiyooka T, Hiramatsu O, Shigeto F, et al. Direct observation of epicardial coronary capillary hemodynamics during reactive hyperemia and during adenosine administration by intravital video microscopy. Am J Physiol Heart Circ Physiol 2005; 288: H1437-43.
17. Zmudka K, Aubert A, Dubiel J, et al. Early intravenous administration of metoprolol enhances myocardial salvage by thrombolysis with recombinant tissue-type plasminogen activator after thrombotic coronary artery occlusion in the dog by improvement of the collateral blood flow to the area at risk. J Am Coll Cardiol 1994; 23: 1499-504.
18. Kucia M, Dawn B, Hunt G, et al. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res 2004; 95: 1191-9.
19. Serruys PW, Wijns W, van den Brand M, et al. Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty. Circulation 1984; 70: 25-36.
20. Hou D, Al-Shaykh E, Brinton TJ, et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: Implications for current clinical trials. Circulation 2005; 112 (9 Suppl.): I150-6.
21. 111 cell labeling. Abstract. J Am Coll Cardiol 2005;45 (Suppl. A): 237A.
22. Sousa ALS, Mesquita CT, Silva SA, et al. Assessment of bone marrow mononuclear cells distribution by radioactive labeling after intracoronary delivery in acute myocardial infarction. Abstract. Am J Cardiol 2005; 96(Suppl.): 70H.
23. Hofmann M, Wollert KC, Meyer GP, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005; 111: 2198-202.
24. Blocklet D, Toungouz M, Berkenboom G, et al. Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells 2006; 24: 333-6.
25. Schächinger V, Erbs S, Elsasser A, et al. Intracoronary Infusion of Bone Marrow-Derived Progenitor Cells in Acute Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled Multicenter Trial (REPAIR-AMI). Late-breaking clinical trials, American Heart Association Scientific Sessions 2005. http://scientificsessions.americanheart.org/portal/scientificsessions
26. Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006; 367: 113-21.
27. Lunde K, Solheim S, Aakhus S, et al. Effects on left ventricular function by intracoronary injections of autologous mononuclear bone marrow cells in acute anterior wall myocardial infarction: The ASTAMI randomized controlled trial. Late-breaking clinical trials. American Heart Association Scientific Sessions 2005. http://scientificsessions.americanheart.org/portal/ scientificsessions
28. Meyer GP, Wollert KC, Drexler H. Eighteen-month results from the BOOST-1 randomized trial. Myocardial Regeneration and Repair: New data from Interventional Clinical Trials, TCT 2005. http://tctmd.com
29. Donahue JK, Heldman AW, Fraser H, et al. Focal modification of electrical conduction in the heart by viral gene transfer. Nat Med 2000; 6: 1395-8.
30. Hedman M, Hartikainen J, Syvanne M, et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003; 107: 2677-83.